↓ Skip to main content

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Overview of attention for article published in Frontiers in immunology, November 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
Published in
Frontiers in immunology, November 2020
DOI 10.3389/fimmu.2020.594271
Pubmed ID
Authors

Long Li, Xiqun Zhu, Yu Qian, Xiangling Yuan, Yi Ding, Desheng Hu, Xin He, Yuan Wu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 16%
Student > Ph. D. Student 10 14%
Student > Doctoral Student 6 9%
Student > Master 5 7%
Researcher 3 4%
Other 7 10%
Unknown 28 40%
Readers by discipline Count As %
Medicine and Dentistry 11 16%
Biochemistry, Genetics and Molecular Biology 9 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Neuroscience 5 7%
Nursing and Health Professions 2 3%
Other 7 10%
Unknown 31 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2022.
All research outputs
#7,783,733
of 25,387,668 outputs
Outputs from Frontiers in immunology
#9,050
of 31,541 outputs
Outputs of similar age
#161,950
of 440,401 outputs
Outputs of similar age from Frontiers in immunology
#326
of 868 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,401 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 868 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.